谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 132 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
YAP1 Induces Bladder Cancer Progression and Promotes Immune Evasion Through IL-6/ STAT3 Pathway and CXCL Deregulation
Pritam Sadhukhan, Mingxiao Feng,Emily J Illingworth,Ido Sloma,Akira Ooki,Andres Matoso,David Sidransky, Burles A Johnson Rd,Luigi Marchionni, Fenna Cm Sillé,Woonyoung Choi, David J McConkey,Mohammad Obaidul Hoque
The Journal of clinical investigation (2024)
引用0浏览0WOS引用
0
0
567P Interim Endoscopic Restaging after Induction Chemotherapy to Predict Complete Response and Survival after Total Neoadjuvant Therapy in Low Rectal Cancer: Ad-hoc Analysis of the IMPACT Trial
E. Shinozaki,H. Osumi,A. Chino, T. Akiyoshi, S. Taguchi,A. Ooki, S. Udagawa, S. Fukuoka, T. Wakatsuki, M. Ogura, K. Chin, S. Matsui, T. Mukai, T. Yamaguchi, N. Miyazaki, Y. Fukunaga, K. Yamaguchi, T. Konishi
Annals of Oncology (2024)
引用0浏览0引用
0
0
1442P Correlation Between Intratumor HER2 Heterogeneity and Circulating Tumor DNA in HER2 Positive Advanced Gastric Cancer: A Phase Ib Trial of HER2 and PD-1 Dual Targeted Therapy (Ni-High) Substudy
H. Osumi, T. Wakatsuki, N. Yamamoto,A. Ooki, K. Chin, H. Shoji, M. Ogura, I. Nakayama, H. Hirano, H. Hara,K. Minashi,E. Shinozaki, K. Kato, S. Kitano, K. Takeuchi, N. Boku, K. Yamaguchi,D. Takahari
Annals of Oncology (2024)
引用0浏览0引用
0
0
Phase 1b Study of Futibatinib Plus Pembrolizumab with or Without Chemotherapy in Patients with Esophageal Carcinoma: Updated Results of Antitumor Activity
Akira Ooki,Kei Muro, Kazumi Nishino, Hisato Kawakami,Hitoshi Ojima,Takashi Kojima,Yoshihiro Tanaka,Kazuo Koyanagi,Nozomu Machida, Susumu Eguchi, Koichi Suyama, Yasutaka Watanabe,Naoki Izawa, Katsunori Iijima, Hiroshi Hirai,Michael Jon Chisamore,Ken Kato
Journal of Clinical Oncologyno. 16_suppl (2024): 4047-4047
引用0浏览0引用
0
0
1465P Potential Impact of APC Mutation on Survival Via Immune Evasion Through WNT Signaling Activation in HER2-positive Gastric Cancer Treated with Trastuzumab (tmab), Nivolumab (nivo), and Chemotherapy
T. Wakatsuki,T. Mashima, N. Yamamoto,A. Ooki, H. Shoji, K. Chin, M. Ogura,K. Kiyotani, I. Nakayama,H. Osumi, S. Fukuoka,E. Shinozaki,K. Minashi, H. Hara, K. Takeuchi,H. Seimiya, S. Kitano, N. Boku, K. Yamaguchi,D. Takahari
Annals of Oncology (2024)
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 132

#Citation: 1550

H-Index: 23

G-Index: 37

Sociability: 6

Diversity: 3

Activity: 44

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn